Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Frank Scott to Adult

This is a "connection" page, showing publications Frank Scott has written about Adult.

 
Connection Strength
  
 
 
0.579
  
  1. Haydek JP, Mohan R, Lew J, Oonk A, Cheng D, Ahmed W, Click B, Fennimore B, Gerich M, Patel SG, Wani S, Hou JK, Scott FI. Treat-to-Target Monitoring Adherence and Rates of Healthcare Utilization in Patients With Inflammatory Bowel Disease in a Regional Healthcare System. Clin Transl Gastroenterol. 2026 Jan 01; 17(1):e00942.
    View in: PubMed
    Score: 0.049
  2. Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, Yuan Y, Kappelman MD, Lewis JD, Singh S. AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease. Gastroenterology. 2025 Dec; 169(7):1397-1448.
    View in: PubMed
    Score: 0.048
  3. Scott FI, Vajravelu RK, Mamtani R, Bianchina N, Mahmoud N, Hou JK, Wu Q, Wang X, Haynes K, Lewis JD. Association Between Statin Use at the Time of Intra-abdominal Surgery and Postoperative Adhesion-Related Complications and Small-Bowel Obstruction. JAMA Netw Open. 2021 02 01; 4(2):e2036315.
    View in: PubMed
    Score: 0.035
  4. Jackson T, Maulsby E, Wilson D, Lalka A, Scott F. A comparison of sugar-tong and volar-dorsal splints for provisional immobilization of distal radius fractures in the adult population. Eur J Orthop Surg Traumatol. 2021 Feb; 31(2):229-234.
    View in: PubMed
    Score: 0.033
  5. Scott FI, Hans AK, Gerich ME, Fennimore B, Mamtani R, Vajravelu RK, Lewis JD. Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's Disease. Clin Gastroenterol Hepatol. 2021 10; 19(10):2082-2092.e10.
    View in: PubMed
    Score: 0.033
  6. Scott FI, Luo M, Shah Y, Lasch K, Vajravelu RK, Mamtani R, Fennimore B, Gerich ME, Lewis JD. Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis. J Crohns Colitis. 2020 Jun 19; 14(5):575-587.
    View in: PubMed
    Score: 0.033
  7. Scott FI, Johnson FR, Bewtra M, Brensinger CM, Roy JA, Reed SD, Osterman MT, Mamtani R, Chen L, Yun H, Xie F, Curtis JR, Lewis JD. Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease. Inflamm Bowel Dis. 2019 04 11; 25(5):925-936.
    View in: PubMed
    Score: 0.030
  8. Scott FI, Shah Y, Lasch K, Luo M, Lewis JD. Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model. Inflamm Bowel Dis. 2018 01 18; 24(2):286-295.
    View in: PubMed
    Score: 0.028
  9. Scott FI, Mamtani R, Haynes K, Goldberg DS, Mahmoud NN, Lewis JD. Validation of a coding algorithm for intra-abdominal surgeries and adhesion-related complications in an electronic medical records database. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):405-12.
    View in: PubMed
    Score: 0.024
  10. Scott FI, Vajravelu RK, Bewtra M, Mamtani R, Lee D, Goldberg DS, Lewis JD. The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):302-309.e11.
    View in: PubMed
    Score: 0.022
  11. Scott FI, Osterman MT, McConnell RA, Lorusso M, Aberra F, Kerner C, Lichtenstein GR, Lewis JD. Impact of JC virus antibody testing in patients with Crohn's disease with loss of response to infliximab: a Markov model. Inflamm Bowel Dis. 2013 Nov; 19(12):2625-33.
    View in: PubMed
    Score: 0.021
  12. Scott FI, Osterman MT, Mahmoud NN, Lewis JD. Secular trends in small-bowel obstruction and adhesiolysis in the United States: 1988-2007. Am J Surg. 2012 Sep; 204(3):315-20.
    View in: PubMed
    Score: 0.019
  13. Ermann J, Hong SJ, Stahly A, Dalal RS, Malik F, Scott FI, Click B, Way A, Davis JM, Shmais M, Raffals LE, Jan R, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland JE, Patel S, Kuhn KA, Weisman MH. Frequency of Spondyloarthritis Symptoms Among US Patients With Inflammatory Bowel Disease: A Cross-Sectional Multi-Center Study. Arthritis Care Res (Hoboken). 2025 Jun; 77(6):777-784.
    View in: PubMed
    Score: 0.011
  14. Hong SJ, Dalal RS, Kuhn KA, Stahly A, Scott FI, Click BH, Way A, Malik F, Davis JM, Shmais M, Raffals LE, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland J, Patel S, Weisman MH, Ermann J, Jan R. Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2025 Oct 01; 120(10):2330-2338.
    View in: PubMed
    Score: 0.011
  15. Rex DK, Bhavsar-Burke I, Buckles D, Burton J, Cartee A, Comar K, Edwards A, Fennimore B, Fischer M, Gerich M, Gilmore A, Hamdeh S, Hoffman J, Ibach M, Jackson M, James-Stevenson T, Kaltenbach T, Kaplan J, Kapur S, Kohm D, Kriss M, Kundumadam S, Kyanam Kabir Baig KR, Menard-Katcher P, Kraft C, Langworthy J, Misra B, Molloy E, Munoz JC, Norvell J, Nowak T, Obaitan I, Patel S, Patel M, Peter S, Reid BM, Rogers N, Ross J, Ryan J, Sagi S, Saito A, Samo S, Sarkis F, Scott FI, Siwiec R, Sullivan S, Wieland A, Zhang J, Repici A, Hassan C, Byrne MF, Rastogi A. Artificial Intelligence for Real-Time Prediction of the Histology of Colorectal Polyps by General Endoscopists. Ann Intern Med. 2024 Jul; 177(7):911-918.
    View in: PubMed
    Score: 0.011
  16. Constant BD, Long MD, Scott FI, Higgins PDR. Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners Survey. Am J Gastroenterol. 2024 Oct 01; 119(10):2070-2078.
    View in: PubMed
    Score: 0.011
  17. Noureldin M, Van T, Cohen-Mekelburg S, Scott FI, Higgins PDR, Stidham RW, Hou J, Waljee AK, Berinstein JA. Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis. Am J Gastroenterol. 2024 Oct 01; 119(10):2130-2133.
    View in: PubMed
    Score: 0.011
  18. Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study. Clin Gastroenterol Hepatol. 2023 06; 21(6):1598-1606.e5.
    View in: PubMed
    Score: 0.010
  19. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed GY. Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2459-2464.
    View in: PubMed
    Score: 0.009
  20. Melmed GY, Oliver B, Hou JK, Lum D, Singh S, Crate D, Almario C, Bray H, Bresee C, Gerich M, Gerner D, Heagy E, Holthoff M, Hudesman D, McCutcheon Adams K, Mattar MC, Metwally M, Nelson E, Ostrov A, Rubin DT, Scott F, Samir S, van Deen W, Younes Z, Oberai R, Weaver A, Siegel CA. Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 12 01; 116(12):2410-2418.
    View in: PubMed
    Score: 0.009
  21. Wang L, Scott FI, Boursi B, Reiss KA, Williams S, Glick H, Yang YX. Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes. Clin Gastroenterol Hepatol. 2022 09; 20(9):1997-2004.e7.
    View in: PubMed
    Score: 0.009
  22. Singh S, Proctor D, Scott FI, Falck-Ytter Y, Feuerstein JD. AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology. 2021 06; 160(7):2512-2556.e9.
    View in: PubMed
    Score: 0.009
  23. Osterman MT, Scott FI, Fogt FF, Gilroy ED, Parrott S, Galanko J, Cross R, Moss A, Herfarth HH, Higgins PDR. Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE). Inflamm Bowel Dis. 2021 01 19; 27(2):207-214.
    View in: PubMed
    Score: 0.009
  24. Kriss M, Te HS, Verna EC, VanWagner LB, Scott FI, Lai JC. National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction. Hepatol Commun. 2021 04; 5(4):701-712.
    View in: PubMed
    Score: 0.009
  25. Mittal C, Dang D, Stoffel E, Menees S, Scott FI, Ahnen D, Patel SG. Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers. Dig Dis Sci. 2020 11; 65(11):3305-3315.
    View in: PubMed
    Score: 0.008
  26. Vajravelu RK, Copelovitch L, Osterman MT, Scott FI, Mamtani R, Lewis JD, Denburg MR. Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age. Clin Gastroenterol Hepatol. 2020 09; 18(10):2262-2268.
    View in: PubMed
    Score: 0.008
  27. Vajravelu RK, Mamtani R, Scott FI, Waxman A, Lewis JD. Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study. Gastroenterology. 2018 11; 155(5):1416-1427.
    View in: PubMed
    Score: 0.007
  28. Vajravelu RK, Scott FI, Mamtani R, Li H, Moore JH, Lewis JD. Medication class enrichment analysis: a novel algorithm to analyze multiple pharmacologic exposures simultaneously using electronic health record data. J Am Med Inform Assoc. 2018 07 01; 25(7):780-789.
    View in: PubMed
    Score: 0.007
  29. Lewis JD, Scott FI, Brensinger CM, Roy JA, Osterman MT, Mamtani R, Bewtra M, Chen L, Yun H, Xie F, Curtis JR. Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-a-Directed Therapy for Inflammatory Bowel Disease. Am J Gastroenterol. 2018 03; 113(3):405-417.
    View in: PubMed
    Score: 0.007
  30. Mudireddy P, Scott F, Feathers A, Lichtenstein GR. Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions. Inflamm Bowel Dis. 2017 10; 23(10):1832-1839.
    View in: PubMed
    Score: 0.007
  31. Agarwal A, Scott FI, Ahmad NA, Chandrasekhara V. Chronic immunosuppression does not potentiate the malignant progression of mucinous pancreatic cystic lesions. Pancreatology. 2016 Sep-Oct; 16(5):900-4.
    View in: PubMed
    Score: 0.006
  32. Mamtani R, Yang YX, Scott FI, Lewis JD, Boursi B. Association of Itraconazole, a Hedgehog Inhibitor, and Bladder Cancer. J Urol. 2016 08; 196(2):343-8.
    View in: PubMed
    Score: 0.006
  33. Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf. 2016 06; 25(6):628-36.
    View in: PubMed
    Score: 0.006
  34. Henao MP, Bewtra M, Osterman MT, Aberra FN, Scott FI, Lichtenstein GR, Kraschnewski J, Lewis JD. Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection. Inflamm Bowel Dis. 2015 Oct; 21(10):2262-71.
    View in: PubMed
    Score: 0.006
  35. Agarwalla A, Small AJ, Mendelson AH, Scott FI, Kochman ML. Risk of recurrent or refractory strictures and outcome of endoscopic dilation for radiation-induced esophageal strictures. Surg Endosc. 2015 Jul; 29(7):1903-12.
    View in: PubMed
    Score: 0.006
  36. Mendelson AH, Small AJ, Agarwalla A, Scott FI, Kochman ML. Esophageal anastomotic strictures: outcomes of endoscopic dilation, risk of recurrence and refractory stenosis, and effect of foreign body removal. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):263-271.e1.
    View in: PubMed
    Score: 0.005
  37. Mamtani R, Haynes K, Finkelman BS, Scott FI, Lewis JD. Distinguishing incident and prevalent diabetes in an electronic medical records database. Pharmacoepidemiol Drug Saf. 2014 Feb; 23(2):111-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)